We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

By LabMedica International staff writers
Posted on 20 Sep 2023

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. More...

Electrolytes are ions that have an electrical charge and are essential for multiple bodily functions such as balancing fluids, transmitting nerve signals, and aiding in muscle contraction and relaxation. Electrolyte analyzers work on the principle of ion-selective electrodes, which can specifically identify certain ions and generate an electrical output corresponding to their concentration. Factors like technological innovations, the rising prevalence of chronic diseases, and the growing demand for point-of-care (POC) testing are driving the growth of the global market for fully automatic electrolyte analyzers. The market was valued at USD 0.44 billion in 2022, and is projected to reach USD 0.77 billion by 2032, registering a CAGR of 5.7% from 2023 to 2032.

These are the latest findings of Allied Market Research (Portland, OR, USA), a full-service market research and business-consulting firm.

Several factors are contributing to the growth of the fully automatic electrolyte analyzers market. Among them are the increasing global demand for POC testing, a growing tendency to adopt fully automatic analyzers, and rising imports of these devices in developing nations. POC testing is gaining traction because it offers quick and precise results right where the patient is, thereby further fueling market growth. However, the steep prices of these automated analyzers are limiting market growth. Despite this, an increased emphasis on preventive healthcare is likely to create new opportunities for market players in the coming years.

On the basis of product type, the integrated segment held the lion's share in 2022, accounting for close to two-thirds of total market revenue. This segment is expected to maintain its leading position and is also projected to grow at the fastest CAGR of 6%, due to increasing preference for integrated over standalone devices. These integrated systems offer quicker processing times and easier data handling because they can be connected to laboratory information systems.

Based on modality, the benchtop segment held the largest share in 2022, accounting for over two-thirds of market revenue. This segment is expected to maintain its dominant position largely due to the extensive range of benchtop models provided by major companies. The portable segment, however, is expected to grow at the fastest CAGR of 6.3% during the forecast period due to the increasing demand for POC testing, which in turn is boosting the demand for portable electrolyte analyzers.

Based on end user, diagnostic centers held the largest market share in 2022, accounting for more than two-fifths of the total revenue. These centers favor automatic analyzers as they allow for quick processing of multiple samples, thereby enabling timely reporting to healthcare professionals. Meanwhile, the hospitals segment is likely to experience the highest CAGR of 6.1% in the forecast period, as rising patient admissions are spurring the adoption of these analyzers in hospital environments.

Based on region, North America led the market in 2022, accounting for nearly two-fifths of the global market revenue and is expected to maintain its dominant position during the forecast period. The North American fully automated electrolyte analyzers market is witnessing notable growth, owing to an increase in the prevalence of chronic diseases such as diabetes and cardiovascular diseases. On the other hand, the Asia-Pacific market is expected to witness the fastest CAGR of 6.5% during the forecast period, owing to an increase in the prevalence of hypertension and rise in adoption of advanced fully automatic electrolyte analyzers in the region.

Related Links:
Allied Market Research 


New
Gold Member
Hematology Analyzer
Medonic M32B
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hematology System
Medonic M16C
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.